Steve Arbitman

Steve Arbitman is a Senior Scientist specializing in Translational Medicine at AstraZeneca, where they focus on advancing healthcare innovations. Prior to this role, they served as an Associate Scientist III at NextCure, Inc., engaging in novel immunotherapy research. Steve also worked as a Scientist in antibody drug conjugate research and has experience as a Research Technologist at The Johns Hopkins University School of Medicine, where they contributed to glycobiology and neurobiology projects. Steve earned a Master of Science in Biotechnology from Johns Hopkins University and holds a Bachelor of Science in Biochemistry from Stevenson University. Previously, they were a Laboratory Technician at ORAU, focusing on virology and GLP cell culture.